Research advances in the role of IL-6/STAT3 signaling pathway in hepatic ischemia-reperfusion injury

VernacularTitle:IL6/STAT3信号通路在肝脏缺血再灌注损伤中的作用研究进展
Author: Yupeng LI ¹ ; Tuxun TUERHONGJIANG· ; Jinming ZHAO
Author Information

1. 新疆医科大学第一附属医院肝脏·腹腔镜外科
Keywords: Interleukin-6 (IL-6); Signal transducer and activator of transcription 3; Hepatic ischemia-reperfusion injury
From: Chinese Journal of Hepatobiliary Surgery 2018;24(5):355-358
CountryChina
Language:Chinese
Abstract: The occurrence and development of hepatic ischemia-reperfusion injury (HIR) has important clinical significance,while interleukin-6 (IL-6) is closely related to HIR and it plays an important role in the signaling pathway between downstream signal transducer and activator of transcription 3 (STAT3).IL-6 has been considered to be a typical proinflammatory cytokine.Activation of the gpl30 homodimer by IL-6 leads to the initiation of Janus kinase (JAK)-STAT path-way that is often constitutively switched on in inflammatory diseases.However,a plethora of studies in the last decade showed that only signaling via the soluble IL-6R (trans-signaling) accounts for the deleterious effects of IL-6,whereas the signaling via the membrane-bound receptor (classic signaling) is essential for the regenerative and anti-inflammatory effects of IL-6.In this paper,the latest progresses in the research field of the IL-6/STAT3 signaling pathway in HIR is discussed.